Signals, Powered By EquityPandit
The French pharmaceutical giant Sanofi and Google have announced a new joint venture that is focused on diabetes care.
The joint venture between the drug maker and Verily which is a subsidiary of Google’s parent company Alphabet, will be focusing on treatments for people living with the chronic disease.
A joint statement said that the details on what the company’s products will look like or when they will reach the market were scant, but they will combine the drugmaker’s clinical know-how with the tech company’s background in analytics and mini devices.
Stefan Oelrich, the head of Sanofi’s diabetes business has said that “As it will initially consist of connecting already existing products, we can expect the first innovations to arrive more quickly than if it was a pharmaceutical research programme starting from scratch.”
